메뉴 건너뛰기




Volumn 14, Issue 1, 2016, Pages

No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial

Author keywords

Fatty liver; NAFLD; Type 2 diabetes; Vitamin D supplementation

Indexed keywords

AMINOTRANSFERASE; COLECALCIFEROL; HEMOGLOBIN A1C; LIPID; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; VITAMIN D;

EID: 84976492685     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/s12916-016-0638-y     Document Type: Article
Times cited : (145)

References (41)
  • 1
    • 0001843697 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease: the most common cause of abnormal liver enzymes in the US population
    • Clark JM, Brancati FL, Diehl AME. Nonalcoholic fatty liver disease: the most common cause of abnormal liver enzymes in the US population. Gastroenterology. 2011;120(5 Suppl 1):A65.
    • (2011) Gastroenterology , vol.120 , Issue.5 , pp. A65
    • Clark, J.M.1    Brancati, F.L.2    Diehl, A.M.E.3
  • 2
    • 84861543083 scopus 로고    scopus 로고
    • The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
    • Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55(6):2005-23.
    • (2012) Hepatology , vol.55 , Issue.6 , pp. 2005-2023
    • Chalasani, N.1    Younossi, Z.2    Lavine, J.E.3    Diehl, A.M.4    Brunt, E.M.5    Cusi, K.6
  • 3
    • 33847629709 scopus 로고    scopus 로고
    • Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease
    • Tolman KG, Fonseca V, Dalpiaz A, Tan MH. Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease. Diabetes Care. 2007;30:734-43.
    • (2007) Diabetes Care. , vol.30 , pp. 734-743
    • Tolman, K.G.1    Fonseca, V.2    Dalpiaz, A.3    Tan, M.H.4
  • 4
    • 84927796763 scopus 로고    scopus 로고
    • Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management
    • McPherson S, Hardy T, Henderson E, Burt AD, Day CP, Anstee QM. Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management. J Hepatol. 2015;62(5):1148-55.
    • (2015) J Hepatol , vol.62 , Issue.5 , pp. 1148-1155
    • McPherson, S.1    Hardy, T.2    Henderson, E.3    Burt, A.D.4    Day, C.P.5    Anstee, Q.M.6
  • 5
    • 11144351102 scopus 로고    scopus 로고
    • The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies
    • Adams LA, Sanderson S, Lindor KD, Angulo P. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J Hepatol. 2005;42:132-8.
    • (2005) J Hepatol. , vol.42 , pp. 132-138
    • Adams, L.A.1    Sanderson, S.2    Lindor, K.D.3    Angulo, P.4
  • 6
    • 79961218135 scopus 로고    scopus 로고
    • Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies
    • Wang C, Wang X, Gong G, Ben Q, Qiu W, Chen Y, et al. Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies. Int J Cancer. 2012;130(7):1639-48.
    • (2012) Int J Cancer , vol.130 , Issue.7 , pp. 1639-1648
    • Wang, C.1    Wang, X.2    Gong, G.3    Ben, Q.4    Qiu, W.5    Chen, Y.6
  • 7
    • 84960447390 scopus 로고    scopus 로고
    • Diabetes mellitus predicts occurrence of cirrhosis and hepatocellular cancer in alcoholic liver and non-alcoholic fatty liver diseases
    • Raff EJ, Kakati D, Bloomer JR, Shoreibah M, Rasheed K, Singal AK. Diabetes mellitus predicts occurrence of cirrhosis and hepatocellular cancer in alcoholic liver and non-alcoholic fatty liver diseases. J Clin Transl Hepatol. 2015;3(1):9-16.
    • (2015) J Clin Transl Hepatol , vol.3 , Issue.1 , pp. 9-16
    • Raff, E.J.1    Kakati, D.2    Bloomer, J.R.3    Shoreibah, M.4    Rasheed, K.5    Singal, A.K.6
  • 9
    • 84942107494 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease is independently associated with early left ventricular diastolic dysfunction in patients with type 2 diabetes
    • Mantovani A, Pernigo M, Bergamini C, Bonapace S, Lipari P, Pichiri I, et al. Nonalcoholic fatty liver disease is independently associated with early left ventricular diastolic dysfunction in patients with type 2 diabetes. PLoS One. 2015;10(8):e0135329.
    • (2015) PLoS One , vol.10 , Issue.8
    • Mantovani, A.1    Pernigo, M.2    Bergamini, C.3    Bonapace, S.4    Lipari, P.5    Pichiri, I.6
  • 10
    • 84958764638 scopus 로고    scopus 로고
    • Non-alcoholic fatty liver disease is a risk factor for the development of diabetic nephropathy in patients with type 2 diabetes mellitus
    • Jia G, Di F, Wang Q, Shao J, Gao L, Wang L, et al. Non-alcoholic fatty liver disease is a risk factor for the development of diabetic nephropathy in patients with type 2 diabetes mellitus. PLoS One. 2015;10(11):e0142808.
    • (2015) PLoS One , vol.10 , Issue.11
    • Jia, G.1    Di, F.2    Wang, Q.3    Shao, J.4    Gao, L.5    Wang, L.6
  • 11
    • 39049102073 scopus 로고    scopus 로고
    • Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients
    • Targher G, Bertolini L, Rodella S, Zoppini G, Lippi G, Day C, et al. Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients. Diabetologia. 2008;51(3):444-50.
    • (2008) Diabetologia , vol.51 , Issue.3 , pp. 444-450
    • Targher, G.1    Bertolini, L.2    Rodella, S.3    Zoppini, G.4    Lippi, G.5    Day, C.6
  • 12
    • 34247605492 scopus 로고    scopus 로고
    • Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients
    • Targher G, Bertolini L, Padovani R, Rodella S, Tessari R, Zenari L, et al. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care. 2007;30(5):1212-8.
    • (2007) Diabetes Care , vol.30 , Issue.5 , pp. 1212-1218
    • Targher, G.1    Bertolini, L.2    Padovani, R.3    Rodella, S.4    Tessari, R.5    Zenari, L.6
  • 13
    • 77957375969 scopus 로고    scopus 로고
    • Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease
    • Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med. 2010;363:1341-50.
    • (2010) N Engl J Med. , vol.363 , pp. 1341-1350
    • Targher, G.1    Day, C.P.2    Bonora, E.3
  • 15
    • 40749094549 scopus 로고    scopus 로고
    • 25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age
    • Hypponen E, Boucher BJ, Berry DJ, Power C. 25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age. Diabetes. 2008;57(2):298-305.
    • (2008) Diabetes , vol.57 , Issue.2 , pp. 298-305
    • Hypponen, E.1    Boucher, B.J.2    Berry, D.J.3    Power, C.4
  • 16
    • 58149346072 scopus 로고    scopus 로고
    • Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000
    • Forouhi NG, Luan J, Cooper A, Boucher BJ, Wareham NJ. Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000. Diabetes. 2008;57:2619-25.
    • (2008) Diabetes. , vol.57 , pp. 2619-2625
    • Forouhi, N.G.1    Luan, J.2    Cooper, A.3    Boucher, B.J.4    Wareham, N.J.5
  • 17
    • 84881159298 scopus 로고    scopus 로고
    • Hypovitaminosis D is independently associated with metabolic syndrome in obese patients
    • Barchetta I, De Bernardinis M, Capoccia D, Baroni MG, Fontana M, Fraioli A, et al. Hypovitaminosis D is independently associated with metabolic syndrome in obese patients. PLoS One. 2013;8(7):e68689.
    • (2013) PLoS One , vol.8 , Issue.7
    • Barchetta, I.1    Bernardinis, M.2    Capoccia, D.3    Baroni, M.G.4    Fontana, M.5    Fraioli, A.6
  • 18
    • 34547485376 scopus 로고    scopus 로고
    • Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease
    • Targher G, Bertolini L, Scala L, Cigolini M, Zenari L, Falezza G, et al. Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis. 2007;17(7):517-24.
    • (2007) Nutr Metab Cardiovasc Dis , vol.17 , Issue.7 , pp. 517-524
    • Targher, G.1    Bertolini, L.2    Scala, L.3    Cigolini, M.4    Zenari, L.5    Falezza, G.6
  • 19
    • 79960152007 scopus 로고    scopus 로고
    • Strong association between nonalcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes
    • Barchetta I, Angelico F, Del Ben M, Baroni MG, Pozzilli P, Morini S, et al. Strong association between nonalcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes. BMC Med. 2011;9:85.
    • (2011) BMC Med. , vol.9 , pp. 85
    • Barchetta, I.1    Angelico, F.2    Ben, M.3    Baroni, M.G.4    Pozzilli, P.5    Morini, S.6
  • 22
    • 84870563131 scopus 로고    scopus 로고
    • Liver vitamin D receptor, CYP2R1, and CYP27A1 expression: relationship with liver histology and vitamin D3 levels in patients with nonalcoholic steatohepatitis or hepatitis C virus
    • Barchetta I, Carotti S, Labbadia G, Gentilucci UV, Muda AO, Angelico F, et al. Liver vitamin D receptor, CYP2R1, and CYP27A1 expression: relationship with liver histology and vitamin D3 levels in patients with nonalcoholic steatohepatitis or hepatitis C virus. Hepatology. 2012;56(6):2180-7.
    • (2012) Hepatology , vol.56 , Issue.6 , pp. 2180-2187
    • Barchetta, I.1    Carotti, S.2    Labbadia, G.3    Gentilucci, U.V.4    Muda, A.O.5    Angelico, F.6
  • 23
    • 53349142350 scopus 로고    scopus 로고
    • 1,25-Dihydroxyvitamin D improved the free fatty-acid-induced insulin resistance in cultured C2C12 cells
    • Zhou QG, Hou FF, Guo ZJ, Liang M, Wang GB, Zhang X. 1,25-Dihydroxyvitamin D improved the free fatty-acid-induced insulin resistance in cultured C2C12 cells. Diab Metab Res Rev. 2004;24:459-64.
    • (2004) Diab Metab Res Rev. , vol.24 , pp. 459-464
    • Zhou, Q.G.1    Hou, F.F.2    Guo, Z.J.3    Liang, M.4    Wang, G.B.5    Zhang, X.6
  • 24
    • 80655127773 scopus 로고    scopus 로고
    • Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats
    • Abramovitch S, Dahan-Bachar L, Sharvit E, Weisman Y, Tov AB, Brazowski E, et al. Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats. Gut. 2011;60:1728-37.
    • (2011) Gut. , vol.60 , pp. 1728-1737
    • Abramovitch, S.1    Dahan-Bachar, L.2    Sharvit, E.3    Weisman, Y.4    Tov, A.B.5    Brazowski, E.6
  • 25
    • 84866382064 scopus 로고    scopus 로고
    • D-livering the message: the importance of vitamin D status in chronic liver disease
    • Kitson MT, Roberts SK. D-livering the message: the importance of vitamin D status in chronic liver disease. J Hepatol. 2012;57(4):897-909.
    • (2012) J Hepatol , vol.57 , Issue.4 , pp. 897-909
    • Kitson, M.T.1    Roberts, S.K.2
  • 26
    • 70350046669 scopus 로고    scopus 로고
    • Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study
    • Feldstein AE, Wieckowska A, Lopez AR, Liu YC, Zein NN, McCullough AJ. Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study. Hepatology. 2009;50:1072-8.
    • (2009) Hepatology. , vol.50 , pp. 1072-1078
    • Feldstein, A.E.1    Wieckowska, A.2    Lopez, A.R.3    Liu, Y.C.4    Zein, N.N.5    McCullough, A.J.6
  • 27
    • 84856388968 scopus 로고    scopus 로고
    • Prospective biopsy-controlled evaluation of cell death biomarkers for prediction of liver fibrosis and nonalcoholic steatohepatitis
    • Joka D, Wahl K, Moeller S, Schlue J, Vaske B, Bahr MJ, et al. Prospective biopsy-controlled evaluation of cell death biomarkers for prediction of liver fibrosis and nonalcoholic steatohepatitis. Hepatology. 2012;55:455-64.
    • (2012) Hepatology. , vol.55 , pp. 455-464
    • Joka, D.1    Wahl, K.2    Moeller, S.3    Schlue, J.4    Vaske, B.5    Bahr, M.J.6
  • 28
    • 84930179342 scopus 로고    scopus 로고
    • A role of 1,25(OH)2D3 supplementation in rats with nonalcoholic steatohepatitis induced by choline-deficient diet
    • Han H, Cui M, You X, Chen M, Piao X, Jin G. A role of 1,25(OH)2D3 supplementation in rats with nonalcoholic steatohepatitis induced by choline-deficient diet. Nutr Metab Cardiovasc Dis. 2015;25(6):556-61.
    • (2015) Nutr Metab Cardiovasc Dis , vol.25 , Issue.6 , pp. 556-561
    • Han, H.1    Cui, M.2    You, X.3    Chen, M.4    Piao, X.5    Jin, G.6
  • 29
    • 84940062431 scopus 로고    scopus 로고
    • High-dose vitamin D supplementation and liver histology in NASH
    • Kitson MT, Pham A, Gordon A, Kemp W, Roberts SK. High-dose vitamin D supplementation and liver histology in NASH. Gut. 2016;65(4):717-8.
    • (2016) Gut , vol.65 , Issue.4 , pp. 717-718
    • Kitson, M.T.1    Pham, A.2    Gordon, A.3    Kemp, W.4    Roberts, S.K.5
  • 30
    • 63149173251 scopus 로고    scopus 로고
    • Standards of medical care in diabetes--2009
    • American Diabetes Association. Standards of medical care in diabetes--2009. Diabetes Care. 2009;32:S13-61.
    • (2009) Diabetes Care , vol.32 , pp. S13-61
  • 31
    • 84872133663 scopus 로고    scopus 로고
    • Validation of terminal peptide of procollagen III for the detection and assessment of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease
    • Tanwar S, Trembling PM, Guha IN, Parkes J, Kaye P, Burt AD, et al. Validation of terminal peptide of procollagen III for the detection and assessment of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease. Hepatology. 2013;57(1):103-11.
    • (2013) Hepatology , vol.57 , Issue.1 , pp. 103-111
    • Tanwar, S.1    Trembling, P.M.2    Guha, I.N.3    Parkes, J.4    Kaye, P.5    Burt, A.D.6
  • 32
    • 84885020653 scopus 로고    scopus 로고
    • Vitamin D: do we get enough? A discussion between vitamin D experts in order to make a step towards the harmonisation of dietary reference intakes for vitamin D across Europe
    • Brouwer-Brolsma EM, Bischoff-Ferrari HA, Bouillon R, Feskens EJ, Gallagher CJ, Hypponen E, et al. Vitamin D: do we get enough? A discussion between vitamin D experts in order to make a step towards the harmonisation of dietary reference intakes for vitamin D across Europe. Osteoporos Int. 2013;24(5):1567-77.
    • (2013) Osteoporos Int , vol.24 , Issue.5 , pp. 1567-1577
    • Brouwer-Brolsma, E.M.1    Bischoff-Ferrari, H.A.2    Bouillon, R.3    Feskens, E.J.4    Gallagher, C.J.5    Hypponen, E.6
  • 33
    • 84862501520 scopus 로고    scopus 로고
    • Low serum 25-hydroxyvitamin D level predicts progression to type 2 diabetes in individuals with prediabetes but not with normal glucose tolerance
    • Deleskog A, Hilding A, Brismar K, Hamsten A, Efendic S, Östenson CG. Low serum 25-hydroxyvitamin D level predicts progression to type 2 diabetes in individuals with prediabetes but not with normal glucose tolerance. Diabetologia. 2012;55(6):1668-78.
    • (2012) Diabetologia , vol.55 , Issue.6 , pp. 1668-1678
    • Deleskog, A.1    Hilding, A.2    Brismar, K.3    Hamsten, A.4    Efendic, S.5    Östenson, C.G.6
  • 34
    • 0032821965 scopus 로고    scopus 로고
    • Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp
    • Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999;22:1462-70.
    • (1999) Diabetes Care. , vol.22 , pp. 1462-1470
    • Matsuda, M.1    DeFronzo, R.A.2
  • 35
    • 70350064027 scopus 로고    scopus 로고
    • Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis
    • Gastaldelli A, Harrison SA, Belfort-Aguilar R, Hardies LJ, Balas B, Schenker S, et al. Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis. Hepatology. 2009;50(4):1087-93.
    • (2009) Hepatology , vol.50 , Issue.4 , pp. 1087-1093
    • Gastaldelli, A.1    Harrison, S.A.2    Belfort-Aguilar, R.3    Hardies, L.J.4    Balas, B.5    Schenker, S.6
  • 37
    • 64949095273 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T
    • Yokoo T, Bydder M, Hamilton G, Middleton MS, Gamst AC, Wolfson T, et al. Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T. Radiology. 2009;251(1):67-76.
    • (2009) Radiology , vol.251 , Issue.1 , pp. 67-76
    • Yokoo, T.1    Bydder, M.2    Hamilton, G.3    Middleton, M.S.4    Gamst, A.C.5    Wolfson, T.6
  • 39
    • 84906940023 scopus 로고    scopus 로고
    • Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial
    • Sharifi N, Amani R, Hajiani E, Cheraghian B. Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial. Endocrine. 2014;47(1):70-80.
    • (2014) Endocrine , vol.47 , Issue.1 , pp. 70-80
    • Sharifi, N.1    Amani, R.2    Hajiani, E.3    Cheraghian, B.4
  • 40
    • 84922227008 scopus 로고    scopus 로고
    • Relationship of vitamin D with insulin resistance and disease severity in non-alcoholic steatohepatitis
    • Bril F, Maximos M, Portillo-Sanchez P, Biernacki D, Lomonaco R, Subbarayan S, et al. Relationship of vitamin D with insulin resistance and disease severity in non-alcoholic steatohepatitis. J Hepatol. 2015;62(2):405-11.
    • (2015) J Hepatol , vol.62 , Issue.2 , pp. 405-411
    • Bril, F.1    Maximos, M.2    Portillo-Sanchez, P.3    Biernacki, D.4    Lomonaco, R.5    Subbarayan, S.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.